Jenny Craig tells staffers it’s winding down its weight-loss centers and warns of mass layoffs

Jenny Craig tells staffers it’s winding down its weight-loss centers and warns of mass layoffs


Jenny Craig has alerted employees to potential mass layoffs as it begins “winding down physical operations” and hunts for a buyer, according to communications the weight-loss company sent some staffers this week.

The company said it “has been going through a sales process for the last couple of months,” according to a document titled “Jenny Craig Company Transition FAQs” that was dated Tuesday and provided to NBC News.

Several Jenny Craig staffers said the company alerted them in recent days about potential layoffs.

The FAQ document said: “While we had to issue Warn Notices specifically for sites where we had more than 50 people potentially impacted, this will likely impact all employees in some manner.

“We do not know the exact employees/groups whom will be impacted, and if any employees may be retained. As a result, we would suggest that you anticipate that your employment may be impacted and begin to seek other employment,” it said.

The federal WARN Act generally requires employers with at least 100 staffers to give workers 60 days’ notice of potential mass layoffs or worksite closures.

It couldn’t be determined how many employees received the document. Spokespeople and executive officers at Jenny Craig didn’t respond to requests for comment.

Bloomberg Law reported last month that the company was pursuing a sale.

Since its launch in 1983, Jenny Craig has been known for its prepared meals and dieting plans, as well as its weight-loss centers that offer in-person consultations with coaches.

The company, based in Carlsbad, California, was acquired by H.I.G. Capital, a $55 billion private equity firm, for an undisclosed amount in April 2019. It operated about 500 company-owned and franchised stores in the U.S. and Canada as of its acquisition, H.I.G. said at the time. H.I.G. didn’t respond to a request for comment.

Dozens of LinkedIn users across the U.S. who list Jenny Craig as their current employer, from on-site workers to corporate staff members, have posted “Open to Work” notices in the past 24 hours.

On Thursday afternoon, Emily Hawkins, Jenny Craig’s chief people officer, posted endorsements of several colleagues on the platform who’d flagged themselves as open to other opportunities. Hawkins didn’t respond to requests for comment.

A current Jenny Craig employee, who spoke anonymously because he wasn’t authorized to discuss internal operations, said the location where he works has been directed to stop taking new clients.

Jenny Craig’s policy is to provide severance pay to laid-off employees “based on job level and tenure with the company,” according to the FAQ document.

“However, at this time, it is highly unlikely that these will be paid,” it said.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More